{"version":"1.0","type":"link","title":"A comparative review of economic evaluations for immune checkpoint inhibitors in early stage and advanced stage cancer: focusing on pembrolizumab.","author_name":"Kim HJ 외","author_url":"https://prs-insight.online/author/Kim%20HJ","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/80085","thumbnail_width":1200,"thumbnail_height":630}